Course Information

13th Annual UCLA Liver Diseases Symposium

The Westin Pasadena
Pasadena, California

October 19, 2019

*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.

Syllabus for Conference Registrants

Download: [ PDF ]

This symposium will serve as an educational forum for the Southern California physician community for the scientific exchange of information regarding the diagnosis, medical and surgical, and treatment of the most prevalent liver diseases.


To enroll click here.

By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
Liver Disease Symposium
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512

By Fax

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620

Course Fees

  • $125 Physicians
  • $75 Allied Health Professionals
  • $25 Fellows and Residents (letter of verification from director required)


No refunds will be granted for this conference, due to the low enrollment fee. A full refund will be provided if for any reason the course must be cancelled or rescheduled.



Francisco Durazo, MD, FACP, FAASLD, FASGE
Professor of Medicine and Surgery
Chief, Transplant Hepatology
Medical Director, Dumont-UCLA Liver Transplant Center

Myron Tong, PhD, MD, FAASLD
Professor of Medicine and Surgery
Director of Clinical Hepatology
Associate Director, UCLA Liver Cancer Center
Director of Asian Liver Center


Vatche Agopian, MD
Associate Professor of Surgery
Associate Director - General Surgery Residency
Department of Surgery

Sheila Ahmadi, MD
Associate Clinical Professor of Medicine, UCLA
Division of Endocrinology

Simon Beaven, MD, PhD
Associate Professor of Medicine
Chief, Division of Gastroenterology & Hepatology
Olive View – UCLA Medical Center
Division of Digestive Diseases and Pfleger Liver Institute

Jihane Benhammou, MD
Transplant Hepatology Fellow
Pfleger Liver Institute

Ronald Busuttil, MD, PhD
William P. Longmire, Jr. Chair in Surgery
Distinguished Professor and Executive Chairman
Chief, Division of Liver and Pancreas Transplantation
Director, Dumont-UCLA Liver Transplant and Cancer Centers

Gina Choi, MD
Assistant Clinical Professor of Medicine and Surgery
Associate Director, Transplant Hepatology Fellowship Program
Pfleger Liver Institute

Erik P. Dutson, MD, FACS
Clinical Professor of Surgery
Chief, Section of Minimally Invasive & Bariatric Surgery
Surgical Director, Center for Obesity &
METabolic Health (COMET)
Executive Director, CASIT

Mohamed El Kabany, MD
Associate Clinical Professor
Division of Digestive Diseases
Pfleger Liver Institute
Antoinette S. Gomes, MD
Professor, Radiology and Medicine
Cardiovascular and Interventional Radiology

Steven Han, MD, AGAF, FAASLD
Professor of Medicine and Surgery
Program Director, Transplant Hepatology Fellowship
Director, Hepatology Clinical Research Center

Jonathan R. Hiatt, MD
Professor of Surgery
Vice Dean for Faculty

Lauren Lemieux, MD
Clinical Instructor
Division of Clinical Nutrition

David Lu, MDCM
Professor of Radiology and Surgery
Director, CT and Cross Sectional Interventional Radiology
Director, Interventional Oncology

Steven Raman, MD, FSAR, FSIR
Professor of Radiology, Urology and Surgery
Division of Abdominal Imaging and Cross Sectional Interventional Radiology
Director, Abdominal Imaging Fellowship Program

Professor of Medicine and Surgery
Adjunct Professor of Nursing
Head, Outcomes Research in Hepatology
Dumont-UCLA Liver Transplant Center

Saeed Sadeghi, MD
Professor of Medicine
Division of Hematology & Oncology
Department of Medicine

Beshoy Yanny, MD
Clinical Instructor, Hepatology
UCLA Santa Monica

Saturday, October 19, 2019

8:30 Introduction
Jonathan R. Hiatt, MD
Moderator: Gina Choi, MD
8:40 Case Presentation
8:50 Hepatitis B: Current Antiviral Treatment, Risk for Hepatocellular Carcinoma?
Myron Tong, PhD, MD, FAASLD
9:10 Case Presentation
9:20 Hepatitis C: Current Antiviral Treatments, Risk for Hepatocellular Carcinoma?
9:40 Panel Discussion – Question and Answer
9:55 Break
Moderator: Francisco Durazo, MD, FACP, FAASLD, FASGE
10:10 Case Presentation
10:20 Nutrition
Lauren Lemieux, MD
10:40 Hepatic Insulin Resistance in Diabetes
Sheila Ahmadi, MD
11:00 Medical Treatment of NASH
Simon Beaven, MD, PhD
11:20 Bariatric Surgery
Erik Dutson, MD, FACS
11:40 Question and Answer
12:00 Lunch
Moderator: Jihane Benhammou, MD
1:30 Refractory Ascites: What To Do?
Mohamed El Kabany, MD
1:50 Lactulose Not Working? Overview of Hepatic Encephalopathy
Beshoy Yanny, MD
2:10 Management of the Other Manifestations of Cirrhosis
Steven Han, MD, AGAF, FAASLD
2:30 Question and Answer
2:45 Break
Moderators: Myron Tong, PhD, MD, FAASLD and Steve Raman, MD, FSAR, FSIR
3:00 Hepatology
Gina Choi, MD

Ronald Busuttil, MD, PhD
Vatche Agopian, MD

Interventional Radiology
Antoinette S. Gomes, MD
David Lu, MDCM

Saeed Sadeghi, MD

Question and Answer
4:20 Closing remarks
Jonathan R. Hiatt, MD
4:30 Adjourn



At the conclusion of this program, participants will be able to: 

  • Identify risk for the development of hepatocellular carcinoma in patients with treated viral hepatitis. 
  • Discuss the management of NASH patients as well as the metabolic syndrome. 
  • Explain management of patients with cirrhosis and its complications. 
  • Implement management of patients with established hepatocellular carcinoma. 
  • Describe interventional radiology assessment and treatment of hepatocellular carcinoma. 
  • Discuss surgical resection for hepatocellular carcinoma. 


The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We, at UCLA, fully endorse the letter and spirit of these concepts.


The Westin Pasadena
191 North Los Robles Avenue
Pasadena, CA 91101
(626) 792-2727


  • Self-parking: $6
  • Valet: $17